📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Predicting post one-year durability of glucose-lowering monotherapies in patients with newly-diagnosed type 2 diabetes mellitus - A MASTERMIND precision medicine approach (UKPDS 87). (2020)

First Author: Agbaje OF

Attributed to: MICA: MRC APBI STratification and Extreme Response Mechanism IN Diabetes - MASTERMIND funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.diabres.2020.108333

PubMed Identifier: 32702468

Publication URI: http://europepmc.org/abstract/MED/32702468

Type: Journal Article/Review

Volume: 166

Parent Publication: Diabetes research and clinical practice

ISSN: 0168-8227